ACU-Serve Acquires Beyond HME, Paving the Way for Strategic Expansion

ACU-Serve

ACU-Serve, a leading provider of healthcare solutions, is proud to announce its recent acquisition of Beyond HME, located in Siesta Key, Florida. This strategic move signals a significant step forward for ACU-Serve as it expands its footprint in the healthcare industry and enhances its service offerings.

The acquisition of Beyond HME, renowned for its exceptional resupply services, aligns seamlessly with ACU-Serve’s commitment to delivering comprehensive and high-quality healthcare solutions to its clients. Beyond HME’s expertise and resources will integrate seamlessly into ACU-Serve’s operations—bolstering its capabilities and enriching the services provided to its valued customers.

“The acquisition of Beyond HME represents a pivotal moment for ACU-Serve as we continue to pursue strategic growth opportunities in the healthcare sector,” said Jim Knight, President of ACU-Serve. “Beyond HME’s reputation for excellence and its focus on re-supply services complement our existing offerings, positioning us for even greater success in meeting the evolving needs of our clients.”

The acquisition process, completed swiftly within the past four months, reflects ACU-Serve’s commitment to agility and efficiency in executing strategic initiatives. As part of the transition, nearly 30 employees from Beyond HME will join the ACU-Serve team, including Margaret Lindskog as the Executive Vice President of Resupply, an accomplished veteran in the healthcare industry. The Beyond HME team will contribute their expertise and dedication to furthering the company’s mission of providing exceptional healthcare solutions.

“At Beyond, our primary goal has been to construct a customer-centric approach, rooted in the values of exceptional patient care and outcomes,” states Jim Dragatsis, CEO of Beyond HME. “Our steadfast belief, like that at ACU-Serve, is that the success of our customers defines our success. We stand poised to elevate resupply at ACU-Serve and to meet their standards of excellence.”

Effective Fri., March 15, 2024, Beyond HME officially became part of the ACU-Serve team, marking the beginning of an exciting new chapter for both organizations and their stakeholders. ACU-Serve looks forward to leveraging the synergies created by this acquisition to drive innovation, enhance customer experiences, and achieve sustained growth.

SourceACU-Serve

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”